Literature DB >> 10966073

Luminacins: a family of capillary tube formation inhibitors from Streptomyces sp. I. Taxomony, fermentation, isolation, physico-chemical properties and structure elucidation.

N Naruse1, R Kageyama-Kawase, Y Funahashi, T Wakabayashi.   

Abstract

A new family of capillary tube formation inhibitors, designated luminacins, has been discovered in the fermentation broth of a soil bacterium. The strain was identified as Streptomyces sp. Mer-VD1207 from taxonomic studies. By means of a series of chromatographic procedures, fourteen structurally related components, luminacins A1, A2, B1, B2, C1, C2, D, E1, E2, E3, F, G1, G2, and H, were isolated, and their structures were elucidated on the basis of spectroscopic analyses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10966073     DOI: 10.7164/antibiotics.53.579

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Total synthesis of luminacin D.

Authors:  J Brad Shotwell; Evan S Krygowski; John Hines; Brian Koh; Elliott W D Huntsman; Hui Won Choi; John S Schneekloth; John L Wood; Craig M Crews
Journal:  Org Lett       Date:  2002-09-05       Impact factor: 6.005

2.  Anti-cancer Effect of Luminacin, a Marine Microbial Extract, in Head and Neck Squamous Cell Carcinoma Progression via Autophagic Cell Death.

Authors:  Yoo Seob Shin; Hyun Young Cha; Bok-Soon Lee; Sung Un Kang; Hye Sook Hwang; Hak Cheol Kwon; Chul-Ho Kim; Eun Chang Choi
Journal:  Cancer Res Treat       Date:  2015-09-09       Impact factor: 4.679

3.  Inhibition of IGF-1-Mediated Cellular Migration and Invasion by Migracin A in Ovarian Clear Cell Carcinoma Cells.

Authors:  Tamami Ukaji; Yinzhi Lin; Kouji Banno; Shoshiro Okada; Kazuo Umezawa
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.